Guggenheim raises BrightSpring Health price target to $84
Bullish analyst view, though the target is an opinion and the stock has already moved higher.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst view, though the target is an opinion and the stock has already moved higher.
What happened, with direct paths to the underlying reporting
Guggenheim raised its target for BTSG; the $84 target is about 23% above the posted price of $68.17. The stock has already risen 0.92 since the signal, so some of the positive move may have occurred.
Target: $84
Posted price: $68.17
Analyst firm: Guggenheim
Analyst: Jason Cassorla
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.